| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LEVETIRACETAM IN SODIUM CHLORIDE | 211356 | 002 | ANDA | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1GM/100ML (10MG/ML) | No | No | 2024/02/12 | 2024/02/12 | HIKMA | Prescription |
| LEVETIRACETAM IN SODIUM CHLORIDE | 211356 | 003 | ANDA | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1.5GM/100ML (15MG/ML) | No | No | 2024/02/12 | 2024/02/12 | HIKMA | Prescription |
| LEVETIRACETAM IN SODIUM CHLORIDE | 209705 | 001 | ANDA | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 500MG/100ML (5MG/ML) | No | No | 2024/02/27 | 2024/02/27 | B BRAUN MEDICAL | Prescription |
| LEVETIRACETAM IN SODIUM CHLORIDE | 209705 | 002 | ANDA | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1GM/100ML (10MG/ML) | No | No | 2024/02/27 | 2024/02/27 | B BRAUN MEDICAL | Prescription |
| LEVETIRACETAM IN SODIUM CHLORIDE | 209705 | 003 | ANDA | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1.5GM/100ML (15MG/ML) | No | No | 2024/02/27 | 2024/02/27 | B BRAUN MEDICAL | Prescription |
| LEVETIRACETAM IN SODIUM CHLORIDE | 219562 | 001 | ANDA | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 500MG/100ML (5MG/ML) | No | No | 2025/01/16 | 2025/01/16 | CAPLIN | Prescription |
| LEVETIRACETAM IN SODIUM CHLORIDE | 219562 | 002 | ANDA | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1GM/100ML (10MG/ML) | No | No | 2025/01/16 | 2025/01/16 | CAPLIN | Prescription |
| LEVETIRACETAM IN SODIUM CHLORIDE | 219562 | 003 | ANDA | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1.5GM/100ML (15MG/ML) | No | No | 2025/01/16 | 2025/01/16 | CAPLIN | Prescription |